{"id":449607,"date":"2026-02-05T21:15:35","date_gmt":"2026-02-05T20:15:35","guid":{"rendered":"https:\/\/medizinonline.com\/nueva-estrategia-en-la-lucha-contra-la-obesidad-y-la-t2d\/"},"modified":"2025-11-21T17:43:02","modified_gmt":"2025-11-21T16:43:02","slug":"nueva-estrategia-en-la-lucha-contra-la-obesidad-y-la-t2d","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/nueva-estrategia-en-la-lucha-contra-la-obesidad-y-la-t2d\/","title":{"rendered":"Nueva estrategia en la lucha contra la obesidad y la T2D"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>El tratamiento de la obesidad y la diabetes de tipo 2 se est\u00e1 desplazando cada vez m\u00e1s hacia los nuevos f\u00e1rmacos de incretina, incluidos los agonistas de los receptores GLP1 (agonistas \u00fanicos como la semaglutida) y los GIP- y GLP1-RA (agonistas duales como la tirzepatida). Sin embargo, a\u00fan se necesitan terapias m\u00e1s potentes y selectivas con un mejor efecto y un perfil de efectos secundarios minimizado. El agonista qu\u00edntuple GLP1:GIP:PanPPAR resulta prometedor en el modelo de rat\u00f3n.  <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fnueva-estrategia-en-la-lucha-contra-la-obesidad-y-la-t2d%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>El tratamiento de la obesidad y la diabetes de tipo 2 se est\u00e1 desplazando cada vez m\u00e1s hacia los nuevos f\u00e1rmacos de incretina, incluidos los agonistas de los receptores GLP1&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fnueva-estrategia-en-la-lucha-contra-la-obesidad-y-la-t2d%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":449614,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Desarrollo de un agonista qu\u00edntuple","footnotes":""},"category":[11552,11483,11352,11475,11408],"tags":[86725,12033,86649,86719,86727,86724,16764,12458,29088,86728,17397,80013,72483],"powerkit_post_featured":[],"class_list":["post-449607","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-el-congreso-informa","category-endocrinologia-y-diabetologia","category-estudios","category-farmacologia-y-toxicologia","tag-agonistas-del-receptor-glp1-2","tag-diabetes-tipo-2-es-2","tag-easd-2025","tag-gip-glp1-ra","tag-glp1gippanppar","tag-medicacion-de-la-incretina","tag-modelo-de-raton","tag-obesidad","tag-perfil-de-efectos-secundarios","tag-quintuple-agonista","tag-semaglutida-es","tag-t2d-es","tag-tirzepatida","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-16 17:48:51","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/449607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=449607"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/449607\/revisions"}],"predecessor-version":[{"id":449616,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/449607\/revisions\/449616"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/449614"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=449607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=449607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=449607"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=449607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}